Home therapy with autologous tumour-infiltrating lymphocytes and subcutaneous interleukin-2 in metastatic melanoma.
Tessier
M H
MH
Pandolfino
M C
MC
Jotereau
F
F
Boudart
D
D
Litoux
P
P
Dréno
B
B
D000328:Adult; D003131:Combined Modality Therapy; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D016219:Immunotherapy, Adoptive; D016898:Interferon-alpha / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D016246:Lymphocytes, Tumor-Infiltrating; D008297:Male; D008545:Melanoma / Q000556:secondary / Q000628:therapy*; D008875:Middle Aged; D012878:Skin Neoplasms; D016896:Treatment Outcome
D016898:Interferon-alpha; D007376:Interleukin-2